Yufu Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Natural Killer Cell-Based Immunotherapy in HCC.

Natural Killer Cell-Based Immunotherapy in HCC.

Journal: Immunology

Published: January 07, 2026

iMCN: information compression-based multimodal confidence-guided fusion network for cancer survival prediction.

iMCN: information compression-based multimodal confidence-guided fusion network for cancer survival prediction.

Journal: Biomedical physics & engineering express

Published: October 10, 2025

Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms.

Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 26, 2025

Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway.

Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway.

Journal: International journal of molecular sciences

Published: December 31, 2024

Research progress on immunotherapy based on NK cells for hepatocellular carcinoma

Research progress on immunotherapy based on NK cells for hepatocellular carcinoma

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: January 21, 2024

Rocaglamide regulates iron homeostasis by suppressing hepcidin expression.

Rocaglamide regulates iron homeostasis by suppressing hepcidin expression.

Journal: Free radical biology & medicine

Published: December 11, 2023

Rocaglamide promotes infiltration and differentiation of T cells and coordinates with PD-1 inhibitor to overcome checkpoint resistance in multiple tumor models.

Rocaglamide promotes infiltration and differentiation of T cells and coordinates with PD-1 inhibitor to overcome checkpoint resistance in multiple tumor models.

Journal: Cancer immunology, immunotherapy : CII

Published: November 22, 2023

Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis.

Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis.

Journal: Journal of leukocyte biology

Published: October 08, 2023

Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway.

Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 26, 2023

Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cells.

Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 18, 2023

DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images.

DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images.

Journal: Journal of translational medicine

Published: May 07, 2023

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.

Journal: Hepatology (Baltimore, Md.)

Published: September 17, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026